Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000818:Animals; D002540:Cerebral Cortex / Q000201:enzymology; D004305:Dose-Response Relationship, Drug; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship; D014970:Xanthines / Q000494:pharmacology
D010726:Phosphodiesterase Inhibitors; D011725:Pyridines; D014970:Xanthines; D010208:Papaverine; D015105:3',5'-Cyclic-AMP Phosphodiesterases